Institutional & Family Asset Management, LLC Dexcom Inc Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$114.22 - $140.1 $39,177 - $48,054	-343 Reduced 52.37%	312 $43,000
Q4 2023 Feb 06, 2024	BUY	$75.49 - $124.16 $40,009 - $65,804	530 Added 424.0%	655 $81,000
Q1 2023 May 08, 2023	SELL	$104.0 - $122.92 $1,144 - $1,352	-11 Reduced 8.09%	125 $14,000
Q2 2022 Aug 08, 2022	BUY	$67.99 - $132.89 $7,274 - $14,219	107 Added 368.97%	136 $10,000
Q1 2022 May 11, 2022	BUY	$94.08 - $130.2 $282 - $390	3 Added 11.54%	29 $15,000
Q2 2021 Aug 10, 2021	BUY	$80.99 - $107.93 $2,105 - $2,806	26 New	26 $11,000
Q4 2020 Feb 03, 2021	SELL	$78.0 - $104.5 $1,638 - $2,194	-21 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$95.51 - $112.95 $2,578 - $3,049	-27 Reduced 56.25%	21 $9,000
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $626 - $1,053	10 Added 26.32%	48 $19,000
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $1,816 - $2,873	38 New	38 $10,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account